FDA issues updated guidance on adapting Covid-19 vaccines, tests and therapeutics for coronavirus variants

The US Food and Drug Administration has issued updated guidance for companies that plan to adapt their Covid-19 medical products -- including vaccines, tests and therapeutics -- to address the emergence of coronavirus variants.

Click Here to read the entire article...